BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38703433)

  • 1. Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.
    Ruiz-García C; Lassaletta L; López-Larrubia P; Varela-Nieto I; Murillo-Cuesta S
    Hear Res; 2024 Jun; 447():109012. PubMed ID: 38703433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
    Samii M; Matthies C; Tatagiba M
    Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.
    Bonne NX; Vitte J; Chareyre F; Karapetyan G; Khankaldyyan V; Tanaka K; Moats RA; Giovannini M
    J Neurooncol; 2016 Aug; 129(1):47-56. PubMed ID: 27177628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
    Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
    J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
    Gehlhausen JR; Park SJ; Hickox AE; Shew M; Staser K; Rhodes SD; Menon K; Lajiness JD; Mwanthi M; Yang X; Yuan J; Territo P; Hutchins G; Nalepa G; Yang FC; Conway SJ; Heinz MG; Stemmer-Rachamimov A; Yates CW; Wade Clapp D
    Hum Mol Genet; 2015 Jan; 24(1):1-8. PubMed ID: 25113746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.
    Chen J; Landegger LD; Sun Y; Ren J; Maimon N; Wu L; Ng MR; Chen JW; Zhang N; Zhao Y; Gao X; Fujita T; Roberge S; Huang P; Jain RK; Plotkin SR; Stankovic KM; Xu L
    Nat Protoc; 2019 Feb; 14(2):541-555. PubMed ID: 30617350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
    Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
    HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2.
    Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
    HNO; 2020 Jan; 68(Suppl 1):60-64. PubMed ID: 31598774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
    Zhao Y; Liu P; Zhang N; Chen J; Landegger LD; Wu L; Zhao F; Zhao Y; Zhang Y; Zhang J; Fujita T; Stemmer-Rachamimov A; Ferraro GB; Liu H; Muzikansky A; Plotkin SR; Stankovic KM; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2077-E2084. PubMed ID: 29440379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Xenograft Model of Vestibular Schwannoma and Hearing Loss.
    Dinh CT; Bracho O; Mei C; Bas E; Fernandez-Valle C; Telischi F; Liu XZ
    Otol Neurotol; 2018 Jun; 39(5):e362-e369. PubMed ID: 29557843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
    Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
    J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2.
    Mautner VF; Nguyen R; Kutta H; Fuensterer C; Bokemeyer C; Hagel C; Friedrich RE; Panse J
    Neuro Oncol; 2010 Jan; 12(1):14-8. PubMed ID: 20150363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.